Last updated at 07 Jul 2024 07:44 PM
Director
DIN: 02150196
Atul Agrawal is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SWAROOP PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02150196.Atul Agrawal is currently involved in 2 different roles. Their most recent position is with SUBH PARENTERAL PRIVATE LIMITED as a Individual Promoter. The first company Atul Agrawal was appointed to as a director was SWAROOP PHARMACEUTICALS PRIVATE LIMITED. Atul Agrawal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Atul Agrawal is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SWAROOP PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02150196.Atul Agrawal is currently involved in 2 different roles. Their most recent position is with SUBH PARENTERAL PRIVATE LIMITED as a Individual Promoter. The first company Atul Agrawal was appointed to as a director was SWAROOP PHARMACEUTICALS PRIVATE LIMITED. Atul Agrawal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
3y 7m 1y 10m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SWAROOP PHARMACEUTICALS PRIVATE LIMITED | Director | 31-Mar-2008 |
| MAN SAFE HEALTH CARE DEVICES PRIVATE LIMITED | Director | 31-Oct-2013 |
| SUBH PARENTERAL PRIVATE LIMITED | Individual Promoter | 03-Feb-2021 |
| SUBH PARENTERAL PRIVATE LIMITED | Director | 03-Feb-2021 |